| Name | Dusigitumab |
|---|
| Description | Dusigitumab (MEDI 573) is a human IgG2λ monoclonal antibody that specifically targets IGF2 and IGF1[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Dusigitumab. IMGT. |
| No Any Chemical & Physical Properties |